{"name":"Memo Therapeutics AG","slug":"memo-therapeutics-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AntiBKV","genericName":"AntiBKV","slug":"antibkv","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AntiBKV","genericName":"AntiBKV","slug":"antibkv","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQTlFVMENHbDBnUTFIMDNNQ211TWJ0WnUzODE1TTV2NUY0NlV2eTZGMS1rYmM3UjNJZ1AtQ1lvQzI4OGxUOXhXRkM3YVVtbHNfODVUdVFqR2NMdjl3N0o2dUcwZEF1dW9lVWZqUDBUcGRCbXJ6czFDckQ0a0tJX0R2STRZQjhjSjZTckhOcXpwSFlWYlRrNVFfbUVVcExXS1A0OVpZ?oc=5","date":"2026-04-06","type":"pipeline","source":"Tracxn","summary":"List of 32 Acquisitions by Lilly (Apr 2026) - Tracxn","headline":"List of 32 Acquisitions by Lilly (Apr 2026)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5SaHpoT3BCMTQtWW5xSkJVOUljallETmpXOHZ2dndjQ2J5QVlHNlRRVlhqaWZWV1otUVIzZnlSWDdsOW9nMkZmbnMta1JBSXRHMWFxZE91V2ZSbWczeEpJdXZ0LTR1MF9uNGVnMFdaMmhwWFdRVG5BN3d2V3JreGc?oc=5","date":"2026-02-10","type":"pipeline","source":"C&EN","summary":"Feb. 10 Business Watch: Biotech IPOs are back; FMC may soon be for sale - C&EN","headline":"Feb. 10 Business Watch: Biotech IPOs are back; FMC may soon be for sale - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxOTGNnV2dIV2FmVk5YNl90SUtidWlMVkNPbmZsTFBXMGk0WnY3VW1KN21FbFhEbkw1UjVtZUdQV0xlUGlocHJteFFYa29yblNTUmNWUGNMM0lqVnVqNkhQUE5mdERmYW95MU1xS2JlRExTdHE5cU14OGR4ejlwLWJjYXRPdG41QVpzallUNllPTFpWSFJfMjdFWFpsZjJTSzlmSjRmVmllLWxUUVg3WFdPLVpUa0pvMk9BMHVlRkx0X0p1Tm9MQmhCZHdvaDFlLUwyaC1Eb3ZPWUZhS3RMVWQ2ZUtlelVYVFR1WjVwWVNLcFpjUnN2d1lWRHROOWZaT2l6eTZKLUZQd2I2R3RKRDh2QkNnU3Qtd1dOSjg1NmNEdlJWZEZyVlBCWG05aU04bHU0?oc=5","date":"2026-02-09","type":"deal","source":"GlobeNewswire","summary":"Memo Therapeutics AG Enters into a Collaboration and Option - GlobeNewswire","headline":"Memo Therapeutics AG Enters into a Collaboration and Option","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPd01kVWd5OGhVWGV4aEZuTVRfdWFmSkJ0SDNWMEVMSGw3M3R3aHRnU0Faejhkbl9VektKOHVmLUtMbURyN21wdkNPWDlzeDc5WlhCM0tRSUlneDNSN28wN0ZWSTBJT1RMQ0JfSEVnaUNseUhENktodWxtVlNfeERucFpyMjBmQ0dIbnRheHhQMG9fbGk5QXBNRy1TZTlZMmswSXYxTGFUdExCSmQzd1Z4UXNGcFVvTXZiS0ZDN0w4MG5Xdw?oc=5","date":"2026-02-09","type":"pipeline","source":"Fierce Biotech","summary":"CSL signs on to $328M research collab with option for Memo's immunoglobulin antibody tech - Fierce Biotech","headline":"CSL signs on to $328M research collab with option for Memo's immunoglobulin antibody tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxONzMydzZwRDRFWENzUl9JZGNRemxGemt6dU5lenJJa0RBN3EtdVdJb0lMaWJRZTlSSEI1OTRJSko1aTVRVWlRQ091UkFhU0pvaFdSUUJhLW5Id1Y3dzZHV1lYbTEyQXZHUHQ0ZmlmcHZqc3NiTjNKV2lfRnY4al9HVnNJTjNpcUpDVGxXR1RsZTItX1hLNXgxLUI5U2p5dzJJ?oc=5","date":"2025-12-23","type":"regulatory","source":"startupticker.ch","summary":"Regulatory approval and a milestone payment for Swiss biotechs - startupticker.ch","headline":"Regulatory approval and a milestone payment for Swiss biotechs","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNUVpYakRuZldFeDVUbFY0Nm5zY1piM1RPV1c1NGNnd2RsY3lsbG1GSGlVTWJyNGhVeFdjYWY0ZkZrLUVxaUVvQWl3RzhGMzFzcXJHcDNrSjMxWUFXLXFTdVpxc2ZwbF9QUjJoSktPWXVHMThPLWh6b3FlNjRxRzJjUzBrV3VjdjJyZ0FTUTlBUmVLVFM0NFBfTXpaZUZkSURXYWZNOE1UY1BlZEptQllHZVpYX3JIRVpxWHp4RkV5NG9hLXhPM0pQdTZYUEQ?oc=5","date":"2025-11-30","type":"regulatory","source":"Reuters","summary":"US FDA memo links 10 child deaths to COVID vaccines - Reuters","headline":"US FDA memo links 10 child deaths to COVID vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOSEZXbXRxdklEQ2VPUnBxVUJYV0pDTXhTZVZDRnBUVnBubWlscHhzNWpzaWxQNUE2ZXJ0ell6anloSzFsTXFlNm5wU0RDOXV0WlFicW1CNzZISXVHQUR4ZEp1NTZGSmpoQ3F4bnNEeGEtY0VTaGNqeWdkQWctZmxuaEZLTnItaTdyQzJxRnRwakZHUnZxaE1feW1obnNaVzZwNzVJTk9DTFcwWXllUlhfcjZTVGdXSGRJX1NLM2xHUERJWUxMVXpJZ3RJcVZWUUx6TEY5N1pB?oc=5","date":"2025-10-27","type":"trial","source":"Investing News Network","summary":"Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth - Investing News Network","headline":"Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE95bDVyUVhfTXJfTlBzeWlILXFPbjZDbVF2RlNFUk5BdllJYzQtNTNRajFVck9vQV9WRWZkdFROcW5HQ2NpNllFZzBvM01fNHNBeF90UmcxdDFWSHdzZk9Ed3NDUENfRkRxOHpmQ1VoVVk?oc=5","date":"2024-06-30","type":"pipeline","source":"The Pharma Letter","summary":"Memo Therapeutics - The Pharma Letter","headline":"Memo Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPcU52cnR5c2k0aXJDM0JRMUlQMG8taUVFSFprOWN3SEh3UG1Va3R6ek5sQlBXUThsbGNYUkFvc2NlYzQwRmcxTHB1WTJ3Wl9vWm9TVkxHek9vNU5JSld4cWNObnBUNVhqcFQxdGpjbXRtY25JU0x5aDA5cE83eTRsamptOXFZczg3aUdCVDFzbjhpbzItZ2tXWDVQYjhyTjd5bUtkelMtRjdiN0pxcUdBMzVwTms2cC1YZ3pObjNnUDgweUJOdWkybktGVQ?oc=5","date":"2023-11-16","type":"pipeline","source":"Business Wire","summary":"Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer - Business Wire","headline":"Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZUt5ZjlCNFRpUmNYRG92Q24zRGRscjg2SENJX1k1U2xNaUl2eUROVjNTdi1JcFZhbERQVTkzdGxJeERZSnBqYmM1S2ZhRmhZS1ZicE1hWE5oTFFXZzBJak1wdW9PLW53dDJDWXdfYmVQVDlpZXI4QzNJYS1rVmtfUHFQdHRvWnZzZnROLVFobGlENldxalBJZUF1RWljM1ZkVm02clV3STdYRmVwRjhkdXVEbXZkWTdl?oc=5","date":"2023-11-02","type":"trial","source":"Pharmaceutical Technology","summary":"Memo Therapeutics raises $27.67m for kidney transplant infection trial - Pharmaceutical Technology","headline":"Memo Therapeutics raises $27.67m for kidney transplant infection trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPd1dUb2xSaTVzY2FBSEc4UmoyMkR6ZjQxaVJGSWZPV2RQR2UwMGZOZllqcTk3WTFnaWVjbmFtemRhdTVDTHZ0NzRyZzQ2NTFNTUVQRFRPZU5uczh1cnNLOTB0WUx4cnQ0UV80ZDJwOXZjY0VVMm1MVHJKbUY4MmNNWDZaaXpTWW0wdWlRTnVKZDdwTkRIeHBiM1dWMA?oc=5","date":"2023-05-02","type":"regulatory","source":"Labiotech.eu","summary":"FDA fast track for Memo’s kidney transplant infection treatment - Labiotech.eu","headline":"FDA fast track for Memo’s kidney transplant infection treatment","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}